Fingerprint
Dive into the research topics of 'Elevated serum HER-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Elevated serum HER-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer
Allan Lipton, S. M. Ali, K. Leitzel, Laurence Demers, Vernon Chinchilli, L. Engle, Harold Harvey, C. Brady, C. M. Nalin, M. Dugan, W. Carney, J. Allard
Research output: Contribution to journal › Article › peer-review
234
Scopus
citations